18 November 2022 in Phenomics
Headache is one of the commonest complaints that doctors need to address in clinical settings. The genetic mechanisms of different types of headache are not well understood while it has been suggested that self-reported headache and self-reported migraine were genetically correlated. In this study, we performed a meta-analysis of genome-wide association studies (GWAS) on the self-reported headache phenotype from the UK Biobank and the self-reported migraine phenotype from the 23andMe using the Unified Score-based Association Test (metaUSAT) software for genetically correlated phenotypes (N = 397,385). We identified 38 loci for headaches, of which 34 loci have been reported before and four loci were newly suggested. The LDL receptor related protein 1 (LRP1)—Signal Transducer and Activator of Transcription 6 (STAT6)—Short chainDehydrogenase/Reductase family 9C member 7 (SDR9C7) region in chromosome 12 was the most significantly associated locus with a leading p value of 1.24 × 10–62 of rs11172113. The One Cut homeobox 2 (ONECUT2) gene locus in chromosome 18 was the strongest signal among the four new loci with a p value of 1.29 × 10–9 of rs673939. Our study demonstrated that the genetically correlated phenotypes of self-reported headache and self-reported migraine can be meta-analysed together in theory and in practice to boost study power to identify more variants for headaches. This study has paved way for a large GWAS meta-analysis involving cohorts of different while genetically correlated headache phenotypes.
3 December 2023 in medRxiv
Purpose: To identify the genetic variants associated with diabetic retinopathy in type 2 patients from the UK Biobank cohort ( n = 17,015) and supporting replication cohorts GODARTS ( n = 5,013), GOSHARE ( n = 1,754), Caucasian Australians ( n = 518), FinnGen ( n = 206,664) and Chinese (n = 1,007). Methods: Totally eleven genome-wide association studies were applied to search for significant genetic variants. Results: We found 5 different loci associated with type 2 diabetic retinopathy in or nearest gene EYA2 , MPDZ , NTNG1 , CTAGE14P and MREGP1 . In the primary GWAS, a significant SNP rs6066146 located in gene EYA2 showed a p value of 4.21 × 10 −8 and may play a role in the development of the disease, with “spleen” reaching a significant level produced by tissue expression analysis. Corresponding heritability of DR was estimated to be 26.73% by SumHer. Among five genes, we found that genes EYA2 , MPDZ , NTNG1 had genetic interactions and may affect the complex development of retinal blood vessels. Conclusion: Diabetic retinopathy is a complication of diabetes that affects the eyes. It is highly likely to occur when high blood sugar damages the retinal blood vessels. There is limited awareness regarding the pathogenesis of DR. Our study identified multiple loci associated with diabetic retinopathy, which may lead to personalized treatments to reduce the burden of the disease.
11 August 2024 in medRxiv
Purpose: Diabetic retinopathy (DR), a complication affecting the eyes, is associated with diabetes. This study aims to identify genetic variants associated with DR in patients with type 1 diabetes in the UK Biobank cohort (n = 1,004). Methods: A genome-wide association study (GWAS) was conducted to identify significant genetic variants of DR in type 1 diabetes. The findings are set to undergo validation during the replication and meta-analysis stages by using six cohorts: African American, European, FinnGen, GoSHARE, GoDARTS and Caucasian Australians. Results: In a locus, top single nucleotide polymorphism (SNP) rs184619214 in CCDC7 reached a GWAS significance level ( p = 6.38 x 10 −9 ) and rs79853754 in ITGB1 ( p = 3.24 x 10 −8 ), with both genes being adjacent to each other. The SNP-based heritability was estimated to be 31.09%. Rs184619214 was replicated and reached statistical significance ( p < 5.0 x 10 −8 ) in the meta-analysis stage. Pathway analysis revealed that ITGB1 is involved in the generation of biomolecules that impact the progression of DR. PheWAS analysis revealed that osteoarthritis (OA) of the hip was significantly associated with most of the SNPs of the locus. Mendelian Randomization further confirmed an association between OA and DR. Conclusions: Our study has identified a novel genomic risk locus associated with DR in type 1 diabetes, located in the intergenic region between the CCDC7 and ITGB1 genes, providing insights for DR researchers.